Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

Integrated Industries has raised ₹101.5 crore through 4.06 crore convertible warrants at ₹25 each, aimed at expanding ...

This plucky retailer has richly rewarded patient investors.

Dividend Kings remain largely overvalued, but six—including MO, UVV, HRL, KVUE, CDUAF, and UBSI—are now fairly priced with ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce that in accordance with its ...

Investing.com -- Akari Therapeutics PLC (NASDAQ:AKTX) stock gained 7.9% in premarket trading Tuesday after the company released preclinical data showing its novel antibody-drug conjugate AKTX-101 ...

This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.

The Rs 922-crore IPO had attracted strong investor demand, getting subscribed nearly 102 times during the bidding window from ...

Ernexa is advancing ERNA-101 through additional preclinical testing, with first-in-human trials planned for next year. The company positions its approach as potentially advantageous by providing a ...

Aequs IPO, focusing on consumer goods and aerospace components, saw an 11.10x subscription by day two. The IPO price band is ₹118-124, with an estimated listing price of ₹165, reflecting a 33.06% ...

TORONTO, ON / ACCESS Newswire / December 10, 2025 / Northern Superior Resources Inc. (“Northern Superior” or the “Company“) (TSXV:SUP)(OTCQB:NSUPF)(GR:D9M1) is pleased to announce the approval by the ...

Shares of Aequs jumped over 12% to touch an intraday high of INR 157 on the BSE following their listing today. The stock ...